Acticor Biotech (France) Market Value
| ALACT Stock | EUR 0.29 0.02 7.41% |
| Symbol | Acticor |
Acticor Biotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Acticor Biotech's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Acticor Biotech.
| 12/13/2022 |
| 12/02/2024 |
If you would invest 0.00 in Acticor Biotech on December 13, 2022 and sell it all today you would earn a total of 0.00 from holding Acticor Biotech SAS or generate 0.0% return on investment in Acticor Biotech over 720 days. Acticor Biotech is related to or competes with Acheter Louer, Spineguard, Vallourec, Manitou BF, Ossiam Minimum, Ekinops SA, and Orapi SA. Acticor Biotech SAS, a clinical stage biopharmaceutical company, develops drugs for the treatment of acute phase of thro... More
Acticor Biotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Acticor Biotech's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Acticor Biotech SAS upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 12.6 | |||
| Information Ratio | 0.0233 | |||
| Maximum Drawdown | 95.62 | |||
| Value At Risk | (22.41) | |||
| Potential Upside | 28.0 |
Acticor Biotech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Acticor Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Acticor Biotech's standard deviation. In reality, there are many statistical measures that can use Acticor Biotech historical prices to predict the future Acticor Biotech's volatility.| Risk Adjusted Performance | 0.0341 | |||
| Jensen Alpha | 0.7395 | |||
| Total Risk Alpha | (2.09) | |||
| Sortino Ratio | 0.0286 | |||
| Treynor Ratio | (0.25) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Acticor Biotech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Acticor Biotech SAS Backtested Returns
Acticor Biotech appears to be out of control, given 3 months investment horizon. Acticor Biotech SAS secures Sharpe Ratio (or Efficiency) of 0.0325, which signifies that the company had a 0.0325% return per unit of risk over the last 3 months. By analyzing Acticor Biotech's technical indicators, you can evaluate if the expected return of 0.51% is justified by implied risk. Please makes use of Acticor Biotech's Mean Deviation of 9.85, downside deviation of 12.6, and Risk Adjusted Performance of 0.0341 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Acticor Biotech holds a performance score of 2. The firm shows a Beta (market volatility) of -1.97, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Acticor Biotech are expected to decrease by larger amounts. On the other hand, during market turmoil, Acticor Biotech is expected to outperform it. Please check Acticor Biotech's value at risk, as well as the relationship between the skewness and day median price , to make a quick decision on whether Acticor Biotech's price patterns will revert.
Auto-correlation | 0.80 |
Very good predictability
Acticor Biotech SAS has very good predictability. Overlapping area represents the amount of predictability between Acticor Biotech time series from 13th of December 2022 to 8th of December 2023 and 8th of December 2023 to 2nd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Acticor Biotech SAS price movement. The serial correlation of 0.8 indicates that around 80.0% of current Acticor Biotech price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.8 | |
| Spearman Rank Test | 0.75 | |
| Residual Average | 0.0 | |
| Price Variance | 2.65 |
Acticor Biotech SAS lagged returns against current returns
Autocorrelation, which is Acticor Biotech stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Acticor Biotech's stock expected returns. We can calculate the autocorrelation of Acticor Biotech returns to help us make a trade decision. For example, suppose you find that Acticor Biotech has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Acticor Biotech regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Acticor Biotech stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Acticor Biotech stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Acticor Biotech stock over time.
Current vs Lagged Prices |
| Timeline |
Acticor Biotech Lagged Returns
When evaluating Acticor Biotech's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Acticor Biotech stock have on its future price. Acticor Biotech autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Acticor Biotech autocorrelation shows the relationship between Acticor Biotech stock current value and its past values and can show if there is a momentum factor associated with investing in Acticor Biotech SAS.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Acticor Stock Analysis
When running Acticor Biotech's price analysis, check to measure Acticor Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acticor Biotech is operating at the current time. Most of Acticor Biotech's value examination focuses on studying past and present price action to predict the probability of Acticor Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acticor Biotech's price. Additionally, you may evaluate how the addition of Acticor Biotech to your portfolios can decrease your overall portfolio volatility.